ISI. V. Sychev

I. V. Sychev

*This is an algorithmically generated author record based on publicly available information.

I. V. Sychev has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Anna V. Lapshtaeva

    National Research Ogarev Mordovia State University

    6 shared publications
  • Darya V. Puzakova

    National Research Ogarev Mordovia State University

    5 shared publications
  • Dmitrij Alekseevitch Sychev

    Petrovsky National Research Centre of Surgery; Russian Medical Academy of Continuous Professional Education

    5 shared publications
  • Raisa Alekseevna Chilova

    I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University)

    3 shared publications
  • А. В. Лапштаева

    ФГБОУ ВО «Национальный исследовательский Мордовский государственный университет имени Н.П. Огарева

    3 shared publications
  • Д. А. Сычев

    ФГБНУ «Российский научный центр хирургии имени академика Б.В. Петровского»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской Федерации

    3 shared publications

Latest Publications

  • Open Access

    Genetic markers GDF9 and BMP15 in predicting pregnancy achievement after IVF

    by A. V. Lapshtaeva, D. V. Puzakova, I. V. Sychev, R. A. Chilova, D. A. Sychev, А. В. Лапштаева, Д. В. Пузакова, И. В. Сычев, Р. А. Чилова, Д. А. Сычев

    Introduction. The GDF9 (growth differentiation factor 9) and BMP15 (bone morphogenetic protein 15) genes encode oocyte-specific growth factors that play a pivotal role in folliculogenesis and embryonic development. Polymorphic variants of these genes may be associated with the outcomes of assisted reproductive technologies. Aim: to evaluate a potential association between polymorphic variants of the GDF9 and BMP15 genes and clinical efficacy of in vitro fertilization (IVF) programs in patients with anovulation-related infertility. Materials and Methods. A prospective study examining 96 women with anovulatory infertility (mean age 30.5 ± 2.5 years) was carried out. Genotyping was performed as part of a genome-wide study using Infinium Global Screening Array-24 v3.0 chips (Illumina, USA) on an iScan system (Illumina) according to the Infinium HTS Assay Guide. Six single nucleotide polymorphisms (SNPs) were analyzed: rs254286 and rs10491279 ( GDF9 ); rs3810682, rs3897937, rs41308602, and rs58995369 ( BMP15 ). Results. Statistically significant associations were found between BMP15 polymorphic variants rs3810682, rs3897937, and rs58995369 and IVF outcomes. The heterozygous C/G genotype of rs3810682 was associated with reduced odds of IVF success (odds ratio (OR) = 0.212; 95 % confidence interval (CI) = 0.071–0.636; p = 0.003). Similar patterns were observed for the C/T genotype of rs58995369 (OR = 0.212; 95 % CI = 0.071–0.636; p = 0.004). For the rs3897937 polymorphism, the homozygous A/A genotype was associated with a markedly increased likelihood of pregnancy (OR = 7.000; 95 % CI = 2.703–18.129; p < 0.001), whereas the heterozygous A/G genotype was associated with decreased odds (OR = 0.083; 95 % CI = 0.028–0.247; p < 0.001). No statistically significant associations with IVF outcomes were detected for GDF9 polymorphisms (rs254286, rs10491279). Conclusion. Polymorphic variants of the BMP15 gene (rs3810682, rs3897937, rs58995369) are associated with IVF outcomes in patients with anovulatory infertility and may serve as potential predictors of IVF success.


  • Open Access

    CYP pharmacogenetic markers as predictors of IVF efficacy in anovulatory infertility

    by A. V. Lapshtaeva, D. V. Puzakova, I. V. Sychev, A. V. Gurbanov, R. A. Chilova, D. A. Sychev, А. В. Лапштаева, Д. В. Пузакова, И. В. Сычев, А. В. Гурбанов, et al.

    Background . Anovulatory infertility remains one of the leading causes of impaired fertility in women of reproductive age. The efficacy of in vitro fertilization (IVF) programs demonstrates interindividual variability, which necessitates the identification of reliable predictive markers to optimize personalized stimulation protocols. The role of pharmacogenetic variants of cytochrome P450 genes in predicting IVF outcomes in this condition remains insufficiently studied, which determines the relevance of this pilot study. Objective . To evaluate the association of polymorphic variants of cytochrome P450 genes (CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5) with the achievement of clinical pregnancy in IVF programs in patients with anovulatory infertility. Materials and methods . This prospective pilot cohort study included 96 patients divided into two groups: those who achieved pregnancy after their first IVF attempt (group 1, n = 48) and those with three or more failed cycles in their history (group 2, n = 48). Genotyping of 19 single‑nucleotide polymorphisms was performed using whole‑genome typing on Infinium Global Screening Array‑24 v3.0 biochips. Statistical analysis included the Pearson χ² test, Fisher's exact test, and the Monte Carlo permutation test (10,000 permutations). Results . Statistically significant associations were identified between polymorphisms in CYP2A6 (rs8192733, rs56113850, rs57897628) and CYP2C19 (rs4244285) and IVF outcomes. For rs8192733, associations were found for the G/G genotype of CYP2A6 with an unsuccessful IVF cycle (OR = 0.105; 95 % CI 0.105–0.316; p < 0.001) and for the C/C and C/G genotypes with a successful procedure (OR = 4.795; 95 % CI 1.212–18.963; p = 0.031 and OR = 3.176; 95 % CI 1.202–8.395; p = 0.031, respectively). For the rs56113850 polymorphism in CYP2A6, the C/T genotype was associated with a favorable outcome (OR = 3.095; 95 % CI 1.284–7.458; p = 0.010), while the T/T genotype was associated with a negative outcome (OR = 0.286; 95 % CI 0.100–0.812; p = 0.015). The homozygous A/A genotype of the rs57897628 polymorphism in CYP2A6 was associated with a lower probability of pregnancy (OR = 0.256; 95 % CI 0.091–0.725; p = 0.005). For the CYP2C19 gene (rs4244285), the G/A genotype was associated with effective IVF (OR = 7.500; 95 % CI 2.016–27.901; p = 0.001). Conclusion . According to the obtained results, CYP gene polymorphisms can serve as potential pharmacogenetic markers for predicting IVF effectiveness in patients with anovulatory infertility.

  • Open Access

    Genetic markers of hormone receptors as predictors of assisted reproductive technologies outcomes in tubal-peritoneal infertility

    by A. V. Lapshtaeva, D. V. Puzakova, I. V. Sychev, R. A. Chilova, D. A. Sychev, А. В. Лапштаева, Д. В. Пузакова, И. В. Сычев, Р. А. Чилова, Д. А. Сычев

    Background. High variability in individual response to controlled ovarian stimulation remains one of the main challenges in assisted reproductive technologies, and the prognostic value of most studied genetic markers shows conflicting results. Objective. To evaluate the association of gonadotropin and sex steroid receptor gene polymorphisms with clinical pregnancy rates in women with tuboperitoneal infertility undergoing in vitro fertilization programs. Materials and methods. This prospective pilot study included 96 patients (25–35 years old) with tuboperitoneal infertility and normal ovarian reserve. Two groups were formed: Group 1 (n=48) — pregnancy on the first attempt; Group 2 (n=48) — patients with a history of three or more previous unsuccessful attempts. The patients received standardized therapy using a short protocol with gonadotropin-releasing hormone antagonists and recombinant FSH. Genotyping was performed using microarray analysis (Infinium Global Screening Array-24 v3.0, Illumina). Results. For the rs3020394 polymorphism of the ESR1 gene, a protective association was established between the A/A genotype (p=0.025; OR=2.553; 95% CI 1.120-5.820) and a negative predictive value of the homozygous G/G genotype. An association was found between the heterozygous C/T genotype of the rs2234693 (PvuII) polymorphism in the ESR1 gene and an unfavorable IVF outcome (p=0.024; OR=0.593; 95% CI 0.170-0.890). Conclusion. The identified associations demonstrate the need for the development and further implementation of pharmacogenetic testing in the comprehensive evaluation of patients with tuboperitoneal infertility as a tool for personalized medicine.

  • Open Access

    CYP2A6 polymorphisms as predictors of IVF efficacy: the role of local estrogen metabolism under hyperestrogenic conditions

    by A. V. Lapshtaeva, I. V. Sychev, D. V. Puzakova, V. V. Eremeev, R. A. Chilova, D. A. Sychev

    Background . The effectiveness of in vitro fertilization (IVF) programs remains limited, which necessitates the search for new prognostic markers. The CYP2A6 gene is expressed in estrogen-sensitive tissues, and its activity is regulated by sex steroids, but the contribution of its polymorphisms to IVF outcomes remains poorly understood. Objective. To determine the association between polymorphic variants of the CYP2A6 gene and IVF outcomes in patients with tubal-peritoneal infertility. Materials and methods . A prospective pilot study included 96 women (mean age 31.4 ± 3.7 years) with tuboperitoneal infertility. All participants received therapy according to a short protocol with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Nine polymorphisms of the CYP2A6 gene were analyzed by genome-wide genotyping on the Illumina iScan platform. Statistical processing was performed using Student's test, χ ² test and Monte- Carlo permutation method. Results . The rs8192733 C/C genotype is associated with a favorable outcome (OR = 6.922; 95 % CI: 2.592–18.486; p Conclusion . An association was established between the CYP2A6 polymorphisms rs8192733 and rs57837628 and the outcomes of IVF programs in tubal-peritoneal infertility. The obtained data demonstrate the potential for their use as additional criteria in personalized patient management protocols in ART cycles.

  • Open Access

    CYP1 polymorphisms and endometrial thickness on the day of ovulation trigger administration

    by A. V. Lapshtaeva, I. V. Sychev, D. V. Puzakova, E. E. Fedorinova, R. A. Chilova, D. A. Sychev

    Background. Endometrial thickness on the day of ovulation trigger administration is a marker demonstrating endometrial readiness for embryo transfer in IVF programs. The proliferative response of the endometrium to stimulation is due to the action of estrogens, the effect of which is determined by the rate of biotransformation, dependent on the activity of cytochrome P450 (CYP). Genetic polymorphism of these enzymes can lead to variability in endometrial response to stimulation. Objective. To determine the association of polymorphic variants of the CYP1A1, CYP1A2, and CYP1B1 genes with endometrial response in IVF programs in women with anovulatory infertility. Materials and methods . The prospective pilot study included 96 patients (mean age 30.5±2.5 years) with anovulatory infertility who received standardized treatment according to a short gonadotropin-releasing hormone antagonist protocol. 13 single nucleotide polymorphisms were genotyped in genes CYP1A1, CYP1A2, CYP1B1 on the Illumina iScan platform. Statistical processing was carried out in the Statistica 12.5 program (StatSoft ). Results . For rs762551 of the gene, endometrial thickness increased from C/C genotype to A/A (p < 0.001; Cohen's d > 0.6). The C/C homozygous genotype rs2470890 was associated with significantly smaller endometrial thickness compared to the C/T (p=0.007) and T/T (p < 0.001) genotypes. Carriers of the C/C genotypes rs10012, A/A rs1056827 and A/A rs2617266 of the CYP1B1 gene had a greater endometrial thickness than carriers of other genotypes (p < 0.05). Conclusion . The found associations of the rs2470890, rs762551 CYP1A2 gene and rs10012, rs1056827, rs2617266 CYP1B1 gene polymorphisms with endometrial thickness on the day of ovulation trigger administration indicate that genetically determined features of estrogen metabolism may directly affect the proliferative response of the endometrium under stimulation, indicating the potential relevance of these markers for personalizing endometrial preparation protocols in IVF cycles.

  • MEDICAL AND SOCIAL ASPECTS OF INFERTILITY

    by Anna Lapshtaeva, Anastasiya Viryasova, Alena Adamchik, Saransk Mordovia Republican Central Clinical Hospital, Ivan Sychev, Aslan Abdullaev

    Significance. To improve effectiveness of assisted reproductive technology (ART) programs, research aimed at finding factors that determine favorable and unfavorable outcomes of the procedure is relevant. The purpose of the study was to identify medical and social characteristics of women in ART program for female infertility, depending on the procedure effectiveness. Material and methods. At the first stage, a retrospective analysis of data from 292 medical records of women completed basic ART program for female infertility was conducted. At the second stage, an anonymous questionnaire survey of a focus group of 100 women completed ART program was conducted. A questionnaire “Attitudes towards ART” was developed specifically for this study. Statistical processing of the results was carried out using the standard application package Stat Soft Statistica 12.0 (U.S.). Results. Factors associated with a favorable outcome of ART program are as follows: registered marriage (OR=6.156 (95% CI =3.239-11.698), p<0.001), early reproductive age 18-35 years (OR=3.068, 95% CI=1.782-5.280), p<0.001), sexual debut after 18 years (OR=1.886, (95% CI=1.184-3.004), p=0.008), duration of infertility from 1 to 3 years (OR=17.733 (95% CI=9.384- 33.511), p<0.001), first attempt (OR=3.165 (95% CI=1.810-5.536), p<0.001). Factors associated with ART program failure include as follows: smoking (OR=2.35 (95% CI=1.19-4.67), p=0.012), sexual debut under 18 years (OR=0.530 (95% CI= 0.333-0.845), p=0.008), history of abortion (OR=4.127 (95% CI=2.525-6.745, p<0.001), infertility over 5 years (OR=33.233 (95% CI=13.513-76.923), p<0.001), three and more attempts in history (OR=8.47 (95% CI=3.460-20.833), p<0.001). In the group of conceived women, they were significantly more likely to know women who completed ART program (p<0.001), their decision was more often supported by their partner/spouse (p<0.05), and close people from the older generation (p=0.038), than in the group of women who failed to conceive. Conclusion. The study results demonstrate the need for activities aimed at: developing a conscious approach to family through promoting family values; preventing sexually transmitted infections and early abortions among young people; early detection of infertility and referral of couples to ART programs; raising public awareness about availability of assisted reproductive technology; organizing provision of psychological support to couples with infertility. Keywords: infertility; factors determining infertility; assisted reproductive technology; in vitro fertilization; induced pregnancy